Correlation Between Swiss Life and BB Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Swiss Life and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swiss Life and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swiss Life Holding and BB Biotech AG, you can compare the effects of market volatilities on Swiss Life and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swiss Life with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swiss Life and BB Biotech.

Diversification Opportunities for Swiss Life and BB Biotech

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Swiss and BION is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Swiss Life Holding and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Swiss Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swiss Life Holding are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Swiss Life i.e., Swiss Life and BB Biotech go up and down completely randomly.

Pair Corralation between Swiss Life and BB Biotech

Assuming the 90 days trading horizon Swiss Life Holding is expected to generate 0.52 times more return on investment than BB Biotech. However, Swiss Life Holding is 1.91 times less risky than BB Biotech. It trades about 0.11 of its potential returns per unit of risk. BB Biotech AG is currently generating about -0.07 per unit of risk. If you would invest  71,760  in Swiss Life Holding on August 25, 2024 and sell it today you would earn a total of  1,600  from holding Swiss Life Holding or generate 2.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Swiss Life Holding  vs.  BB Biotech AG

 Performance 
       Timeline  
Swiss Life Holding 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Swiss Life Holding are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Swiss Life may actually be approaching a critical reversion point that can send shares even higher in December 2024.
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Swiss Life and BB Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Swiss Life and BB Biotech

The main advantage of trading using opposite Swiss Life and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swiss Life position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.
The idea behind Swiss Life Holding and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon